
Overview
Julia Wattacheril, MD, MPH is an associate professor of medicine, physician scientist, inventor and director of the Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) program at Columbia University Irving Medical Center. Her clinical and translational work spans the multidisciplinary care of MASLD patients at all stages of their disease to the investigation of rare genetic variants influencing the development and progression of MASLD before and after liver transplantation. She currently leads an interdisciplinary research group using machine learning to identify at-risk and protected phenotypes within the electronic health record (EHR) for multi-omic analysis. Of particular interest for clinical outcomes discovered through EHR phenotyping include rapid progression to advanced liver disease, need for transplantation and hepatocellular carcinoma. Awards include the Department of Surgery Innovation Award and Columbia Department of Biomedical Engineering Ignition Award for these software applications as they move into medicine.Wattacheril is the lead principal investigator for several clinical trials in MASH. Her early pilot work with proteomics and lipidomics in the development of metabolic dysfunction associated steatohepatitis (MASH) led to her current efforts investigating multi-omic signatures associated with fibrotic MASH. She co-led a multicenter consortium investigating the clinical risks associated with the development of hepatocellular carcinoma in patients with all etiologies of chronic liver disease, with a particular local focus on diverse populations. At Columbia, she works closely with the Center for Precision Medicine and Genomics to integrate genomics into clinical care. She mentors across disciplines including computational geneticists to masters’ program students in nutrition to undergraduates in psychology. She has a commitment to community education, including faith-based and non-profit sectors.
Dr. Wattacheril is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Visceromegaly, Enlarged Liver, Liver Transplant, and Endoscopy.
Dr. Wattacheril is board certified in Gastroenterology and Transplant Hepatology. She is actively involved in clinical research, co-authoring 33 peer reviewed articles and participating in 4 clinical trials. Dr. Wattacheril is currently accepting new patients.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
Locations
622 West 168th Street, Floor 14, New York, NY 10032
Additional Areas of Focus
Dr. Wattacheril has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
4 Clinical Trials
Atlantic Medical Group Gastroenterology At Summit
Nikolaos Pyrsopoulos is a Transplant Surgeon and a Gastroenterologist practicing medicine in Summit, New Jersey. Dr. Pyrsopoulos is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Liver Failure, Hepatitis, Hepatorenal Syndrome, Liver Transplant, and Endoscopy. Dr. Pyrsopoulos is board certified in American Board Of Internal Medicine. Dr. Pyrsopoulos is currently accepting new patients.
CUIMC/Presbyterian Hospital And Vanderbilt Clinic
Dr. Gene Im is a transplant hepatologist and the Director of the Alcohol-associated Liver Disease Program at Columbia known as ADAPT (Advanced inter-Disciplinary Alcohol liver Program and Treatment), a patient-centered, integrated care and research program for patients with alcohol-associated liver disease (ALD). ADAPT is one of only a few integrated ALD clinics in the country.Dr. Im is an internationally recognized expert in ALD, including alcohol-associated hepatitis and liver transplantation based on his clinical focus and research achievements. He has co-authored several practice-changing articles, including the 2019 ALD Practice Guidance from AASLD, the 2024 MetALD Expert Position Statement, and the first experience of early liver transplantation for alcohol-associated hepatitis in North America.Currently, he is the Vice-Chair of the AASLD ALD Special Interest Group and serves on the Editorial Board for the journal Liver Transplantation. Dr. Im is also the founder of ALD-ALLY (Alcohol-associated Liver Disease patients deserve ALcohol LiteracY), an annual conference focused on actionable initiatives for advancing the science and care of patients with alcohol use disorder and ALD (www.ald-ally.com)Dr. Im is an Assistant Professor of Medicine in the Center for Liver Disease and Transplantation and Division of Digestive and Liver Diseases at Columbia University. Dr. Im is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Hepatitis, Alcoholic Cirrhosis, Liver Failure, Liver Transplant, and Hepato-Pancreato-Biliary Surgery. Dr. Im is board certified in Gastroenterology and Transplant Hepatology. Dr. Im is currently accepting new patients.
Northwell Health Physician Partners Sandra Atlas Bass Center For Liver Diseases
Dr. Sanjaya K. Satapathy is the medical director of the Center for Liver Disease and Transplantation at the Northwell Transplant Institute, program director of Northwell's Transplant Hepatology Fellowship, and professor of medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.His path to medicine began in India, where he was inspired by his father an engineer with a passion for homeopathy to pursue a career in healthcare. He earned his medical degree from Veer Surendra Sai Medical College, followed by fellowship training in gastroenterology and hepatology in the early 2000s. During that time, he witnessed the profound need for liver transplantation in India, where access remained scarce.While presenting his research at a conference in the United States, Dr. Satapathy was drawn to the opportunities and possibilities for advancing transplantation in America. He decided to continue his career in the United States, completing additional residency and fellowship training before serving as a transplant hepatologist in Memphis. In 2019, he was recruited to Northwell.It was a dream to begin from zero and build a transplant program that could be a model not just for the area or the state, but for the country, says Dr. Satapathy. Within only a few years, we've been able to achieve that goal, because Northwell has all the elements and resources to be one of the best programs in the nation. The expertise we have is unparalleled, with a collaborative team that encompasses all levels of care.The program was founded just in time for a huge surge in demand for liver transplants in the area, he adds. Liver disease and other liver issues are on the rise, making the need for an extensive program crucial for those in the New York region. Part of the program's strength is innovation. For example, Northwell is utilizing an approach that allows donated organs to be safely preserved for a longer period of time, which means needed organs can travel longer distances even from as far away as Hawaii. Northwell is also running several clinical trials on transplant medications and operates a robust transplant hepatology fellowship program to train the next generation of doctors a program Dr. Satapathy launched.I'm passionate about this work, and particularly about my patients, he says. I see every patient as my family, and my focus is on what I can do next to help them. Dr. Satapathy is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Spontaneous Bacterial Peritonitis, Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH), Liver Transplant, and Endoscopy. Dr. Satapathy is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Gastroenterology, and American Board Of Internal Medicine/Transplant Hepatology.
Frequently Asked Questions about Dr. Julia J. Wattacheril
How do I make an appointment with Dr. Julia J. Wattacheril?
You can book an appointment with Dr. Julia J. Wattacheril by calling their office at 212-305-0914. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Julia J. Wattacheril a top-rated expert for Non-Alcoholic Fatty Liver Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Julia J. Wattacheril is classified as an Distinguished expert for Non-Alcoholic Fatty Liver Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Julia J. Wattacheril specialize in?
While Dr. Julia J. Wattacheril is a Gastroenterology, they have specific expertise in Non-Alcoholic Fatty Liver Disease, Visceromegaly, and Enlarged Liver. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.
Does Dr. Julia J. Wattacheril participate in research or clinical trials?
Yes. Dr. Julia J. Wattacheril has published 33 articles and abstracts on conditions like Non-Alcoholic Fatty Liver Disease. You can view a list of Dr. Julia J. Wattacheril's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Julia J. Wattacheril accept my insurance?
Dr. Julia J. Wattacheril accepts most major insurance plans, including Cigna and EmblemHealth. We recommend calling the office directly at 212-305-0914 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Enlarged LiverDr. Wattacheril isDistinguished. Learn about Enlarged Liver.
- Non-Alcoholic Fatty Liver DiseaseDr. Wattacheril isDistinguished. Learn about Non-Alcoholic Fatty Liver Disease.
- VisceromegalyDr. Wattacheril isDistinguished. Learn about Visceromegaly.
- Advanced
- Alcoholic CirrhosisDr. Wattacheril isAdvanced. Learn about Alcoholic Cirrhosis.
- Banti's SyndromeDr. Wattacheril isAdvanced. Learn about Banti's Syndrome.
- CirrhosisDr. Wattacheril isAdvanced. Learn about Cirrhosis.
- Esophageal VaricesDr. Wattacheril isAdvanced. Learn about Esophageal Varices.
- HepatitisDr. Wattacheril isAdvanced. Learn about Hepatitis.
- Nonalcoholic Steatohepatitis (NASH)Dr. Wattacheril isAdvanced. Learn about Nonalcoholic Steatohepatitis (NASH).
- Experienced
- AscitesDr. Wattacheril isExperienced. Learn about Ascites.
- Autoimmune HepatitisDr. Wattacheril isExperienced. Learn about Autoimmune Hepatitis.
- Caroli DiseaseDr. Wattacheril isExperienced. Learn about Caroli Disease.
- CholangitisDr. Wattacheril isExperienced. Learn about Cholangitis.
- EndoscopyDr. Wattacheril isExperienced. Learn about Endoscopy.
- Fibrolamellar CarcinomaDr. Wattacheril isExperienced. Learn about Fibrolamellar Carcinoma.


